However, it’s important to note that the Embark study only utilized conventional imaging, leaving the effectiveness of PSMA PET/CT unaddressed, despite its emerging role in detecting prostate cancer recurrence, even in low levels of PSA [45]. This evidence concerns the gene KLK3 and prostate cancer.